Table 1.
Author, Year | Site | Study Design | Sample Size | Stage of Lactation | Measure Maternal Obesity | Nutrients Assessed | ||
---|---|---|---|---|---|---|---|---|
Milk Fat or TGs | Milk Protein | Milk Lactose or Carbohydrates | ||||||
Aleali, 2018 [23] | Iran | Longitudinal | 51 | 1, 2, 3, and 4 wk | BMI | √ | √ | √ |
Antonakou, 2013 [24] | Greece | Longitudinal | 64 | 1, 3, and 6 mo | BMI | √ | ||
Aumeistere, 2017 [25] | Latvia | Cross-sectional | 28 | 2–21 mo | BMI | √ | ||
Barbosa, 1997 [26] | Mexico | Longitudinal | 40 | 3 and 6 mo | BMI | √ | √ | √ |
Brown, 1986 [27] | Bangladesh | Intervention | 58 | 1–9 mo | Arm circumference, skinfold | √ | √ | √ |
Bzikowska-Jura, 2018 [28] | Poland | Longitudinal | 40 | 1, 3, and 6 mo | BMI, BIA | √ | √ | √ |
Chang, 2015 [8] | Korea | Cross-sectional | 2,632 | 0–8 mo | BMI | √ | √ | √ |
DeLuca, 2016 [29] | France | Cross-sectional | 100 | 1 mo | BMI | √ | √ | √ |
Dritsakou, 2017 [30] | Greece | Longitudinal | 305 | 3, 7, and 30 day | BMI | √ | √ | √ |
Eilers, 2011 [31] | Germany | Longitudinal | 77 | 3 and 28 day | BMI | √ | √ | |
Fujimori, 2015 [32] | Brazil | Cross-sectional | 68 | 2–3 day | BMI | √ | √ | |
Gridneva, 2018 [33] | Australia | Longitudinal | 20 | 2, 5, 9, and 12 mo | BMI, BIS | √ | ||
Jans, 2015 [34] | Belgium | Cross-sectional | 48 | 4 day | BMI | √ | √ | √ |
Jans, 2018 [35] | Belgium | Longitudinal | 75 | 3 or 4 day and 1–6 wk | BMI | √ | √ | √ |
Kierson, 2006 [36] | USA | Cross-sectional | 20 | 7–21 day | BMI | √ | ||
Kugananthan, 2017 [16] | Australia | Longitudinal | 59 | 2, 5, 9, and 12 mo | BMI, BIS | √ | √ | |
Kurniati, 2016 [37] | Indonesia | Cross-sectional | 48 | 1 mo | BMI, BIA | √ | ||
Kwon, 2017 [38] | USA | Cross-sectional | 44 | 2–14 wk | BMI | √ | √ | |
Lemas, 2016 [39] | USA | Cross-sectional | 30 | 2 wk | BMI | √ | √ | √ |
Ley, 2012 [40] | Canada | Longitudinal | 170 | 1 or 7 day and 3 mo | BMI | √ | √ | |
Makela, 2013 [41] | Finland | Cross-sectional | 163 | 3 mo | BMI | √ | ||
Mangel, 2017 [42] | Israel | Cross-sectional | 109 | 1–2 day | BMI | √ | √ | √ |
Nommsen, 1991 [43] | USA | Longitudinal | 92 | 3, 6, 9, and 12 mo | Skinfold, % IBW | √ | √ | √ |
Panagos, 2016 [9] | USA | Cross-sectional | 42 | 4–10 wk | BMI | √ | √ | √ |
Quinn, 2012 [44] | Philippines | Cross-sectional | 102 | 0–18 mo | BMI, skinfold | √ | √ | √ |
Rudolph, 2017 [45] | USA | Longitudinal | 48 | 2 wk and 4 mo | BMI | √ | ||
Schueler, 2013 [46] | USA | Cross-sectional | 13 | 29–38 day | BMI, waist circumference, DXA | √ | ||
Villalpando, 1992 [47] | Mexico | Cross-sectional | 30 | 4 or 6 mo | BMI, skinfold | √ | √ | √ |
Villalpando, 2001 [48] | Mexico | Intervention | 10 | 5–6 mo | BMI, skinfold | √ | ||
Yang, 2014 [49] | China | Cross-sectional | 436 | 5–11, 12–30, 31–60, 61–120 or 121–240 day | BMI | √ | √ | √ |
Young, 2017 [50] | USA | Longitudinal | 56 | 2 wk and 4 mo | BMI | √ | √ | √ |
1 BIA, bioelectrical impedance analysis; BIS, bioelectrical impedance spectroscopy; BMI, body mass index; DXA, dual-energy X-ray absorptiometry; mo, month(s); wk, week(s); TGs, triglycerides; %IBW, pre-pregnancy percent ideal body weight. The checkmark symbol indicates which macronutrient was assessed by each study.